Anti-inflammatory effects of aloe vera gel in human colorectal mucosa in vitro

Alimentary Pharmacology and Therapeutics

Volumn 19, Issue 5, 2004, Pages 521-527

  Langmead, L ^a   Makins, R J ^a   Rampton, D S ^a,b  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b ROYAL LONDON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALOE VERA EXTRACT; ICOSANOID; INTERLEUKIN 8; PROSTAGLANDIN E2; REACTIVE OXYGEN METABOLITE; THROMBOXANE B2;

ADULT; AGED; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CELL STRAIN CACO 2; CHEMOLUMINESCENCE; COLON BIOPSY; COLON MUCOSA; DOSE RESPONSE; ENTERITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GEL; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; RECTUM BIOPSY; RECTUM MUCOSA;

ADULT; AGED; ALOE; ANTI-INFLAMMATORY AGENTS; CACO-2 CELLS; COLITIS, ULCERATIVE; EICOSANOIDS; FEMALE; GELS; HUMANS; INTERLEUKIN-8; INTESTINAL MUCOSA; MALE; MIDDLE AGED; PHYTOTHERAPY; PLANT EXTRACTS; REACTIVE OXYGEN SPECIES;

EID: 1642332211     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2004.01874.x     Document Type: Article

References (30)

1. Grindlay D, Reynolds T. The aloe vera phenomenon: a review of the properties and modern uses of leaf parenchyma gel. J Ethnopharmacol 1986; 16: 117-51.
2. Langmead L, Chitnis M, Rampton DS. Use of complementary therapies by patients with IBD may indicate psychosocial distress. Inflamm Bowel Dis 2002; 8: 174-9.
3. Syed TA, Ahmad SA, Holt AH, Ahmad SH, Afzal M. Management of psoriasis with Aloe vera extract in a hydrophilic cream: a placebo-controlled, double-blind study. Trop Med Int Health 1996; 1: 505-9.
4. Grisham MB. Oxidants and free radicals in inflammatory bowel disease. Lancet 1994; 344: 859-61.
5. Simmonds NJ, Rampton DS. Inflammatory bowel disease - a radical view. Gut 1993; 34: 865-8.
6. Rampton DS, Hawkey CJ. Prostaglandins and ulcerative colitis. Gut 1984; 25: 1399-413.
7. Gibson P, Rosella O. Interleukin 8 secretion by colonic crypt cells in vitro: response to injury suppressed by butyrate and enhanced in inflammatory bowel disease. Gut 1995; 37: 536-43.
8. Daig R, Andus T, Aschenbrenner E, Falk W, Scholmerich J, Gross V. Increased interleukin 8 expression in the colon mucosa of patients with inflammatory bowel disease. Gut 1996; 38: 216-22.
9. Keshavarzian A, Fusunyan RD, Jacyno M, Winship D, MacDermott RP, Sanderson IR. Increased interleukin-8 (IL-8) in rectal dialysate from patients with ulcerative colitis: evidence for a biological role for IL-8 in inflammation of the colon. Am J Gastroenterol 1999; 94: 704-12.
10. Powell-Tuck J, Day DW, Buckell NA, Wadsworth J, Lennard-Jones JE. Correlations between defined sigmoidoscopic appearances and other measures of disease activity in ulcerative colitis. Dig Dis Sci 1982; 27: 533-7.
11. Baron J, Connell A, Lennard-Jones A. Variation between observers in describing mucosal appearances in proctocolitis. Br Med J 1964; 1: 189-92.
12. Simmonds NJ, Millar AD, Blake DR, Rampton DS. Antioxidant effects of aminosalicylates and potential new drugs for inflammatory bowel disease: assessment in cell-free systems and inflamed human colorectal biopsies. Aliment Pharmacol Ther 1999; 13: 363-72.
13. Millar AD, Rampton DS, Chander CL, et al. Evaluating the antioxidant potential of new treatments for inflammatory bowel disease using a rat model of colitis. Gut 1996; 39: 407-15.
14. Langmead L, Dawson C, Hawkins C, Banna N, Loo S, Rampton DS. Antioxidant effects of herbal therapies used by patients with inflammatory bowel disease: an in vitro study. Aliment Pharmacol Ther 2002; 16: 197-205.
15. Bland J. Clinical measurement - repeatability and precision measurement. In: An Introduction to Medical Statistics, 3rd edn. Oxford: Oxford University Press, 1991: 267-8.
16. Glazer AN. Phycoerythrin fluorescence-based assay for reactive oxygen species. Methods Enzymol 1990; 186: 161-8.
17. Peskar BM, Dreyling KW, Peskar BA, May B, Goebell H. Enhanced formation of sulfidopeptide-leukotrienes in ulcerative colitis and Crohn's disease: inhibition by sulfasalazine and 5-aminosalicylic acid. Agents Actions 1986; 18: 381-3.
18. Carty E, Macey M, McCartney SA, Rampton DS. Ridogrel, a dual thromboxane synthase inhibitor and receptor antagonist: anti-inflammatory profile in inflammatory bowel disease. Aliment Pharmacol Ther 2000; 14: 807-17.
19. Perneger TV. What's wrong with Bonferroni adjustments [see comments]. Br Med J 1998; 316: 1236-8.
20. Marshall J. Aloe vera gel: what is the evidence? Pharm J 1990; 240: 360-2.
21. Allen RC, Pruitt BA Jr. Humoral-phagocyte axis of immune defense in burn patients. Chemiluminogenic probing. Arch Surg 1982; 117: 133-40.
22. t'Hart LA, Nibbering PH, van den Barselaar MT, van Dijk H, van den Berg AJ, Labadie RP. Effects of low molecular constituents from Aloe vera gel on oxidative metabolism and cytotoxic and bactericidal activities of human neutrophils. Int J Immunopharmacol 1990; 12: 427-34.
23. Lee KY, Weintraub ST, Yu BP. Isolation and identification of a phenolic antioxidant from Aloe barbadensis. Free Radic Biol Med 2000; 28: 261-5.
24. Singh RP, Dhanalakshmi S, Rao AR. Chemomodulatory action of Aloe vera on the profiles of enzymes associated with carcinogen metabolism and antioxidant status regulation in mice. Phytomedicine 2000; 7: 209-19.
25. Yagi A, Kabash A, Mizuno K, Moustafa SM, Khalifa TI, Tsuji H. Radical scavenging glycoprotein inhibiting cyclooxygenase-2 and thromboxane A2 synthase from aloe vera gel. Planta Med 2003; 69: 269-71.
26. Sabeh F, Wright T, Norton SJ. Purification and characterization of a glutathione peroxidase from the Aloe vera plant. Enzyme Protein 1993; 47: 92-8.
27. Esteban A, Zapata JM, Casano L, Martin M, Sabater B. Peroxidase activity in Aloe barbadensis commercial gel: probable role in skin protection. Planta Med 2000; 66: 724-7.
28. Sabeh F, Wright T, Norton SJ. Isozymes of superoxide dismutase from Aloe vera. Enzyme Protein 1996; 49: 212-21.
29. Vazquez B, Avila G, Segura D, Escalante B. Anti-inflammatory activity of extracts from Aloe vera gel. J Ethnopharmacol 1996; 55: 69-75.
30. Jain A, Basal E. Inhibition of Propionibacterium acnes-induced mediators of inflammation by Indian herbs. Phytomedicine 2003; 10: 34-8.